American Thoracic Society Conference 2017

OracleBio will be exhibiting at the 2017 American Thoracic Society (ATS) Conference, which takes place from the 19th to the 24th of May in Washington D.C.

ATS Conference

OracleBio are pleased to have data presented on two posters at the conference:

Quantification of Differential Fibrotic Lesions by Image Analysis in the Mouse Bleomycin Model of Pulmonary Fibrosis
Tuesday 23rd May, 11.15am – 1.00pm
Fibrosis: Current and Future Approaches Session
Poster Board Number: P32
Produced in collaboration with Charles River and Grünenthal

Respiratory Function and Quantitative Measurement of Fibrosis in a Rat Model of Bleomycin-Induced Lung Fibrosis’
Tuesday 23rd May, 11.15am – 1:00pm
Fibrosis: Current and Future Approaches Session
Poster Board Number: P22
Produced in collaboration with Charles River

OracleBio’s US Business Development Manager, Matt Gaffney and Senior Project Manager, Mark Anderson will be at Booth 1349 throughout the conference.  If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with Mark and Matt during the event, please contact us.

The American Thoracic Society improves global health by advancing research, patient care and public health in pulmonary disease, critical illness and sleep disorders. The annual conference brings together over 16,000 clinicians, researchers and health care professionals to hear ground breaking research and experience hands-on training. To find out more about the ATS, please click here.

OracleBio provides a range of digital pathology services that support clinical and pre-clinical Pharmaceutical R&D. For more details on how our services can support your research, please click here. 

To keep up to date with all OracleBio news and events, please follow us on LinkedIn by clicking the button below: